Skip to content

BBNX BBNX Proceeds from Maturities, Prepayments and Calls of Short-Term Investments

Proceeds from Maturities, Prepayments and Calls of Short-Term Investments at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's proceeds from maturities, prepayments and calls of short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's proceeds from maturities, prepayments and calls of short-term investments?
BBNX (BBNX) reported proceeds from maturities, prepayments and calls of short-term investments of $48M in Q1 2026.
How has BBNX's proceeds from maturities, prepayments and calls of short-term investments changed year-over-year?
BBNX's proceeds from maturities, prepayments and calls of short-term investments increased by 71.4% year-over-year, from $28M to $48M.